Nachrichten zur Pfizer Inc. Aktie

Down 63%, Should You Buy the Dip on Pfizer?

Pfizer has taken its lumps lately. Its time to wonder whether the stock can make a comeback.…

Pfizer Stock Analysis: Buy, Sell, or Hold?

Pfizers (NYSE: PFE) management team is confident in its 2025 opportunities. Where to invest $1,000 right now? Our analyst team just…

Pfizer bid to expand Talzenna use in prostate cancer questioned by FDA panel

…

Pfizer Buy

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Pfizer angesichts der Lizenzierung eines Krebsmedikaments aus China…

Jefferies hebt Ziel für Pfizer auf 33 Dollar - Buy

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Pfizer angesichts der Lizenzierung eines Krebsmedikaments aus China…

The Zacks Analyst Blog Highlights Pfizer, Coca-Cola and The Walt Disney

Pfizer, Coca-Cola and The Walt Disney are part of the Zacks top Analyst Blog.…

2 High-Yield Dividend Stocks to Buy Right Now

Though there are plenty of dividend stocks on the market, they arent all created equal. Consider that the average dividend…

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

Resilient and growing. Those two descriptions definitely apply to the healthcare sector. People need healthcare products and services regardless of…

MRNA, PFE Stocks Jump Despite FDAs Stricter Standards for COVID-19 Shots

Though the new FDA rules limit access to COVID-19 booster vaccines, the commitment to high-risk groups lifts Moderna, Pfizer and…

Pfizer Aktie steigt um 2% - 1,25 Mrd. USD Deal mit 3SBio für Krebs-Therapie

Frankfurt (www.aktiencheck.de) - Pfizer-Aktienanalyse von XTB: Die Experten von XTB nehmen die Aktie von Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol:…

Jefferies belässt Biontech auf Buy - Ziel 149 Dollar

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Biontech auf "Buy" mit einem Kursziel von 149 US-Dollar belassen. Die…

Pfizer Thinks Bigger With 3SBio Deal

…

Pfizer Signs Experimental Drug Licensing Agreement With 3SBio

Pfizer inks Experimental Drug Licensing Deal With China-based company 3SBio.…

Pfizer signs $6bn licensing deal with China’s 3SBio for cancer drug

Pfizer Inc (NYSE:PFE, ETR:PFE) has agreed a licensing deal worth up to $6 billion with Chinese biopharmaceutical group 3SBio to develop…

These 3 Dividend Stocks Yield More Than 6% and Their Payouts Look Safe

If you see a stock that pays 6% in dividends, you might assume its too risky -- but thats not…

Pfizer Aktienanalyse: 3SBio-Deal, Q1 2025 Zahlen & Analystenkommentare

Bad Marienberg (www.aktiencheck.de) - Pfizer Aktienanalyse: 3SBio-Deal, Q1 2025 Zahlen & Analystenkommentare Pfizer Aktienanalyse: Milliarden-Deal mit 3SBio & solide…

Pfizer: Auf den Spuren von BioNTech – Milliarden-Deal!

Der Pharma-Riese Pfizer stärkt erneut sein Entwicklungsportfolio. Die US-Amerikaner sind dieses Mal in China fündig geworden und haben einen milliardenschweren…

Pfizer signs up to $6 billion licensing deal with Chinas 3SBio for cancer drug

Pfizer has signed a licensing agreement worth up to $6 billion with Chinese pharmaceutical products developer 3SBio Inc for the…

Pfizer signs up to $6 billion licensing deal with China’s 3SBio for cancer drug By Reuters

Pfizer signs up to $6 billion licensing deal with China’s 3SBio for cancer drug…

Pfizers Turnaround Story Is Stronger Than You Think

…

Heres How Many Shares of Pfizer You Should Own to Make $10,000 in Annual Dividend Income @themotleyfool #stocks $PFE

…

US House panel seeks information from Pfizer over alleged COVID vaccine delay By Reuters

US House panel seeks information from Pfizer over alleged COVID vaccine delay…

Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer

StoneCo, Centene, CVS Health and Pfizer have been highlighted in this Screen of The Week article.…

ROUNDUP/SMS an Pfizer: Von der Leyen kassiert Schlappe vor Gericht

LUXEMBURG (dpa-AFX) - Die "New York Times" hat im Rechtsstreit um die Herausgabe von SMS von…

ROUNDUP/SMS an Pfizer: Von der Leyen kassiert Schlappe vor Gericht

LUXEMBURG (dpa-AFX) - Die "New York Times" hat im Rechtsstreit um die Herausgabe von SMS von EU-Kommissionspräsidentin Ursula von der…

POLITIK: Schlappe für von der Leyen im Prozess um SMS an Pfizer-Chef

LUXEMBURG (dpa-AFX) - Im Rechtsstreit um Textnachrichten an einen Pharma-Konzernchef hat EU-Kommissionspräsidentin Ursula von der Leyen…

Urteil zu von der Leyens SMS an Pfizer-Chef erwartet

LUXEMBURG (dpa-AFX) - Das Gericht der EU urteilt am Mittwoch zur Herausgabe der SMS-Nachrichten von EU-Kommissionspräsidentin Ursula von der Leyen…

Should Value Investors Buy Pfizer (PFE) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…

The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen

J&J, Eli Lilly, Pfizer, Merck, Amgen are included in this Analyst Blog.…

Pfizer, Merck, Johnson & Johnson to lose billions to Trumps latest executive order

The President is scheduled to sign an Executive Order on Monday to upend the entire pharmaceutical industry.…

Wondering if Pfizers 7.6% Dividend Yield Is Sustainable? Heres What You Need to Know. @themotleyfool #stocks $PFE

…

Wondering if Pfizers 7.6% Dividend Yield Is Sustainable? Heres What You Need to Know.

Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmakers exceptionally juicy dividend these days has made…

Zacks.com featured highlights PCB, G-III Apparel, Gibraltar, Pfizer and Pampa Energia

PCB, G-III Apparel, Gibraltar, Pfizer and Pampa Energia have been highlighted in this Screen of The Week article.…

Pfizer (PFE) Just Overtook the 20-Day Moving Average

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?…

Can Pfizer (PFE) Climb 25.14% to Reach the Level Wall Street Analysts Expect?

The mean of analysts price targets for Pfizer (PFE) points to a 25.1% upside in the stock. While this highly…

Giants of Cancer Care® announces the 13th annual class of inductees

This event is supported by Pfizer, DSI and Regeneron. This event is supported by Pfizer, DSI and Regeneron.…

Why BioNTech Stock Got Trounced on Tuesday

An unhealthy combination of factors resulted in an unhealthy day on the stock market for next-generation healthcare company BioNTech (NASDAQ:…

Why Viking Therapeutics Stock Surged Nearly 20% Higher in April

One of the best catalysts for a stocks rise is the withdrawal of a rival. That was an important dynamic…

Pfizer Stock Up 5% Following Q1 Results: Time to Buy, Sell or Hold?

Investors may stay invested in PFE stock to see how its new growth drivers perform.…

Pfizer Aktie: Kursziel angehoben

Zürich (www.aktiencheck.de) - Rating-Update: Trung Huynh, Analyst der UBS, stuft die Aktie von Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol: PFE,…

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

If youre looking for blue chip stocks, theres no better place to start than the Dow Jones Industrial Average (DJINDICES:…

Zacks.com featured highlights Fox, Universal Technical Institute, Pfizer, Tenet Healthcare and Newmont

Fox, Universal Technical Institute, Pfizer, Tenet Healthcare and Newmont have been highlighted in this Screen of The Week article.…

Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks

Top-ranked stocks Fox (FOXA), Universal Technical Institute (UTI), Pfizer (PFE), Tenet Healthcare (THC) and Newmont (NEM) are likely to beat…

Pfizer plant Übernahme bei Adipositas & Co – diese 3 Kandidaten sind hochspannend

Der US-Pharmakonzern Pfizer hat am Dienstag seine Zahlen zum ersten Quartal präsentiert (DER AKTIONÄR berichtete: „Pfizer: Prognose steht – 7,5…

Pfizers Q1 Update May Mark A Bottom In The Stock

…

Pfizers CEO said the company could make tremendous investments in the US if Trumps tariffs go away

Albert Bourla said Pfizer is being "frugal" with investments because of the uncertainty surrounding tariffs.…

Buy Pfizer (PFE) Stock for a Rebound After Crushing Q1 EPS Expectations?

Pfizer (PFE) shares spiked 3% in Tuesdays trading session as the pharmaceutical giant was able to crush its Q1 earnings…

Jefferies belässt Pfizer auf Buy - Ziel 32 Dollar

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Pfizer nach Zahlen auf "Buy" mit einem Kursziel…

JPMorgan belässt Pfizer auf Neutral - Ziel 30 Dollar

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer nach Zahlen auf "Neutral" mit einem Kursziel…

Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D

It comes as drugmakers brace for Trumps levies on pharmaceuticals imported into the U.S. – his administrations bid to boost…